|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.980 USD | +2.05% |
|
+4.93% | -17.45% |
| 07-28 | Altimmune, Inc. - Special Call | |
| 07-28 | Altimmune Announces Positive Topline Results from Reclaim Phase 2 Trial of Pemvidutide in Alcohol Use Disorder | CI |
| Market Cap | 580M 503M 467M 431M 812M 55.33B 827M 5.53B 2.17B 27.48B 2.18B 2.13B 92.41B | P/E 2026 * |
-4.83x | P/E 2027 * | -4.44x |
|---|---|---|---|---|---|
| Enterprise Value | 135M 117M 109M 100M 189M 12.89B 193M 1.29B 505M 6.4B 507M 496M 21.53B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99.59% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Altimmune, Inc.
| 1 day | +2.05% | ||
| 1 week | +4.93% | ||
| Current month | -1.97% | ||
| 1 month | -1.97% | ||
| 3 months | +14.62% | ||
| 6 months | -46.79% | ||
| Current year | -17.45% |
| 1 week | 2.8 |  | 3.31 |
| 1 month | 2.75 | | 3.31 |
| Current year | 2.56 | | 6.44 |
| 1 year | 2.56 | | 6.44 |
| 3 years | 2.09 | | 14.84 |
| 5 years | 2.09 | | 23.49 |
| 10 years | 1.51 | | 237.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jerome Durso
CEO | Chief Executive Officer | 58 | 01/01/2026 |
Gregory Weaver
DFI | Director of Finance/CFO | 70 | 11/11/2024 |
Rachel Garner
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Hodges
BRD | Director/Board Member | 58 | 01/09/2003 |
Mitchel Sayare
CHM | Chairman | 78 | 01/01/2018 |
Klaus Schafer
BRD | Director/Board Member | 76 | 01/07/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/26/26 A | Free | Chief Technology Officer | 318,100 | 0.2540% | ||
| 2/26/26 A | Free | Chief Financial Officer | 370,000 | 0.2955% | ||
| 1/31/26 A | Free | Executive/Senior Manager | 4,571 | 0.0044% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.05% | +4.93% | -18.36% | -8.31% | 580M | |
| -0.81% | -0.33% | +27.15% | +81.12% | 55.23B | |
| +2.54% | -4.82% | +28.80% | +67.53% | 53.75B | |
| -0.11% | +0.86% | -15.63% | -13.56% | 23.48B | |
| -1.58% | -5.51% | -3.51% | +375.36% | 22B | |
| +2.33% | -1.07% | +20.12% | -12.29% | 19.78B | |
| +0.28% | -1.49% | +28.73% | -33.60% | 17.44B | |
| +0.37% | -6.03% | +16.11% | +539.31% | 14.66B | |
| +1.16% | +0.58% | +51.87% | +181.96% | 14.07B | |
| -5.09% | -10.87% | +153.11% | +272.20% | 13.02B | |
| Average | +0.12% | -1.00% | +28.84% | +144.97% | 23.4B | |
| Weighted average by Cap. | +0.27% | -0.43% | +27.57% | +124.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -107M -92.9M -86.27M -79.56M -150M -10.21B -153M -1.02B -400M -5.07B -402M -393M -17.05B | -130M -113M -105M -96.72M -182M -12.41B -185M -1.24B -486M -6.16B -488M -478M -20.73B |
| Net Debt | -444M -386M -359M -331M -623M -42.44B -634M -4.24B -1.66B -21.08B -1.67B -1.63B -70.88B | -340M -295M -274M -253M -476M -32.44B -485M -3.24B -1.27B -16.11B -1.28B -1.25B -54.18B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | $2.980 | +2.05% | 5,439,362 |
| 29/07/26 | $2.920 | -2.34% | 8,301,360 |
| 28/07/26 | $2.990 | +1.01% | 17,142,614 |
| 27/07/26 | $2.960 | +6.86% | 4,060,013 |
| 24/07/26 | $2.770 | -2.46% | 1,911,556 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALT Stock
Select your edition
All financial news and data tailored to specific country editions
